Bo Peng - Harbin Med Univ, Harbin Med Univ

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comprehensive Analysis of PPP4C’s Impact on Prognosis, Immune Microenvironment, and Immunotherapy Response in Lung Adenocarcinoma Using Single-Cell Sequencing and Multi-Omics

Kaiyu Wang,Bo Peng,Ran Xu,Tong Lu,Xiaoyan Chang,Zhiping Shen,Jiaxin Shi, Meifeng Li,Chenghao Wang,Xiang Zhou,Chengyu Xu,Hao Chang,Linyou Zhang

FRONTIERS IN IMMUNOLOGY (2024)

引用1浏览0WOS引用

Identification of Immunotherapy Biomarkers for Improving the Clinical Outcome of Homologous Recombination Deficiency Patients with Lung Adenocarcinoma

Xiang Zhou,Rongjian Xu,Tong Lu,Ran Xu,Chenghao Wang,Bo Peng,Xiaoyan Chang,Zhiping Shen,Kaiyu Wang,Jiaxin Shi,Jiaying Zhao,Lin-You Zhang

AGING-USno. 16 (2023): 8090-8112

引用0浏览0WOS引用

Immunogenic Cell Death-Based Prognostic Model for Predicting the Response to Immunotherapy and Common Therapy in Lung Adenocarcinoma

Xiang Zhou,Ran Xu,Tong Lu,Chenghao Wang,Xiaoyan Chang,Bo Peng,Zhiping Shen,Lingqi Yao,Kaiyu Wang,Chengyu Xu,Jiaxin Shi, Ren Zhang,Jiaying Zhao,Linyou Zhang

SCIENTIFIC REPORTS（2023）

引用1浏览0WOSNATURE引用

An Anoikis-Based Gene Signature for Predicting Prognosis in Malignant Pleural Mesothelioma and Revealing Immune Infiltration

Jiaxin Shi,Bo Peng,Xiang Zhou,Chenghao Wang,Ran Xu,Tong Lu,Xiaoyan Chang,Zhiping Shen,Kaiyu Wang,Chengyu Xu,Linyou Zhang

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGYno. 13 (2023): 12089-12102

引用1浏览0WOS引用

Development and Validation of a Nomogram for Predicting Overall Survival of Resected N2 Non-Small Cell Lung Cancer Patients Undergoing Neoadjuvant Radiotherapy

Jiaxin Shi,Bo Peng,Chenghao Wang,Xiang Zhou,Tong Lu,Ran Xu,Xiaoyan Chang,Zhiping Shen,Kaiyu Wang,Chengyu Xu,Linyou Zhang

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGYno. 13 (2023): 11779-11790

引用2浏览0WOS引用

Preoperative Computed Tomography-Based Tumoral Radiomic Features Prediction for Overall Survival in Resectable Non-Small Cell Lung Cancer

Bo Peng,Kaiyu Wang,Ran Xu,Congying Guo,Tong Lu,Yongchao Li,Yiqiao Wang,Chenghao Wang,Xiaoyan Chang,Zhiping Shen,Jiaxin Shi,Chengyu Xu,Linyou Zhang

FRONTIERS IN ONCOLOGY（2023）

引用4浏览0WOS引用

A Bioinformatics-Based Immune-Related Prognostic Index for Lung Adenocarcinoma That Predicts Patient Response to Immunotherapy and Common Treatments

Chenghao Wang,Tong Lu,Ran Xu,Xiaoyan Chang,Shan Luo,Bo Peng,Jun Wang,Lingqi Yao,Kaiyu Wang,Zhiping Shen,Jiaying Zhao,Linyou Zhang

Journal of Thoracic Disease（2022）

引用3浏览0WOS引用

Identification of a Prognostic Index System and Tumor Immune Infiltration Characterization for Lung Adenocarcinoma Based on Mrna Molecular of Pyroptosis

Huawei Li,Xiaoyan Chang, Haiyan Wang,Bo Peng,Jun Wang,Pengfei Zhang,Linyou Zhang

Frontiers in Medicine（2022）

引用2浏览0WOS引用

Mitochondrial Homeostasis–Related Lncrnas Are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma

Bo Peng,Han Lou, Chen, Lei Wang,Huawei Li,Tong Lu,Ruisi Na,Ran Xu,Tong Xin,Lingqi Yao,Henghui Xu,Kaiyu Wang,Xin Liu,Linyou Zhang

Frontiers in Genetics（2022）

引用5浏览0WOS引用

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for Mrna Vaccine Development

Ran Xu,Tong Lu,JiaYing Zhao,Jun Wang,Bo Peng,LinYou Zhang

Frontiers in Cell and Developmental Biology（2022）

引用11浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn